Print this Page

Ground View

From new medical products to jobs, the California life sciences industry contributes greatly to the state and beyond. We must continue to protect and nurture these biomedical innovation ecosystems so they can thrive and serve the needs of millions of Californians and patients around the world. Throughout this website, California biomedical innovation will be highlighted. From groundbreaking treatments to unique business collaborations to thought-provoking clinical work, California is at the forefront. The following snapshots give insight into three sectors of the biomedical industry, biopharmaceuticals, diagnostics, and medical devices, represented by Medivation, Illumina, and Tandem Diabetes.

SNAPSHOT:
BIOPHARMACEUTICALS
Medivation
(NASDAQ: MDVN)

Medivation
Medivation
“California has a certain legacy and spirit of innovation, risk taking and entrepreneurialism that I believe are essential in making life sciences companies successful.”

Co-Founder and CEO, Medivation

Read more…

SNAPSHOT:
DIAGNOSTICS
Illumina
(OTC: ILMN)

Illumina
Illumina
“Innovation is at the heart of the life sciences industry. If you look at a technology category such as next-generation sequencing – it has evolved even faster than the speed of computing over the last decade. At Illumina, we believe these types of innovations will move into the clinic quickly and ultimately transform healthcare.”

Jay Flatley, President and CEO, Illumina

Read more…

SNAPSHOT:
MEDICAL DEVICES
Tandem
Diabetes Care

Tandem Diabetes Care
Tandem Diabetes Care
“Innovation is important to every industry, but there is such an unmet need in the life sciences, and healthcare in general, that technological innovation has to be part of the solution if we want to make a meaningful impact.”

Kim Blickenstaff, CEO of Tandem Diabetes Care

Read more…

Permanent link to this article: http://www.californiabiomedreport.com/defining-biomedical-industry-ground-view/